Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021149

Expand all

OVIDREL (CHORIOGONADOTROPIN ALFA)
EQ 0.25MG /0.5ML Marketing Status: Prescription

Active Ingredient: CHORIOGONADOTROPIN ALFA
Proprietary Name: OVIDREL
Dosage Form; Route of Administration: INJECTABLE; SUBCUTANEOUS
Strength: EQ 0.25MG /0.5ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N021149
Product Number: 002
Approval Date: Oct 6, 2003
Applicant Holder Full Name: EMD SERONO INC
Marketing Status:  Prescription
Patent and Exclusivity Information

OVIDREL (CHORIOGONADOTROPIN ALFA)
0.25MG/VIAL Marketing Status: Discontinued

Active Ingredient: CHORIOGONADOTROPIN ALFA
Proprietary Name: OVIDREL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.25MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021149
Product Number: 001
Approval Date: Sep 20, 2000
Applicant Holder Full Name: EMD SERONO INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English